Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis
Hemasphere. 2023 Mar 30;7(4):e860.
doi: 10.1097/HS9.0000000000000860.
eCollection 2023 Apr.